 | • レポートコード：GIR-105X06729 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、女性用不妊治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。女性用不妊治療薬の種類別市場規模（非経口、経口、その他）、用途別市場規模（不妊治療クリニック、病院、クライオバンク）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・女性用不妊治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Allergan Plc、Ferring BV、Merck KGaA、Novartis AG、Sanofi ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：非経口、経口、その他 ・用途別分析2016年-2026年：不妊治療クリニック、病院、クライオバンク ・女性用不妊治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・女性用不妊治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・女性用不妊治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・女性用不妊治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・女性用不妊治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Female Infertility Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Female Infertility Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Female Infertility Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Female Infertility Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Parenteral
Oral
Others
Market segment by Application can be divided into
Fertility Clinics
Hospitals
Cryobanks
The key market players for global Female Infertility Drugs market are listed below:
Allergan Plc
Ferring BV
Merck KGaA
Novartis AG
Sanofi
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Female Infertility Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Female Infertility Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Parenteral
1.2.3 Oral
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Female Infertility Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Fertility Clinics
1.3.3 Hospitals
1.3.4 Cryobanks
1.4 Global Female Infertility Drugs Market Size & Forecast
1.4.1 Global Female Infertility Drugs Sales in Value (2016-2026))
1.4.2 Global Female Infertility Drugs Sales in Volume (2016-2026)
1.4.3 Global Female Infertility Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Female Infertility Drugs Production Capacity Analysis
1.5.1 Global Female Infertility Drugs Total Production Capacity (2016-2026)
1.5.2 Global Female Infertility Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Female Infertility Drugs Market Drivers
1.6.2 Female Infertility Drugs Market Restraints
1.6.3 Female Infertility Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Allergan Plc
2.1.1 Allergan Plc Details
2.1.2 Allergan Plc Major Business
2.1.3 Allergan Plc Female Infertility Drugs Product and Services
2.1.4 Allergan Plc Female Infertility Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Ferring BV
2.2.1 Ferring BV Details
2.2.2 Ferring BV Major Business
2.2.3 Ferring BV Female Infertility Drugs Product and Services
2.2.4 Ferring BV Female Infertility Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Merck KGaA
2.3.1 Merck KGaA Details
2.3.2 Merck KGaA Major Business
2.3.3 Merck KGaA Female Infertility Drugs Product and Services
2.3.4 Merck KGaA Female Infertility Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business
2.4.3 Novartis AG Female Infertility Drugs Product and Services
2.4.4 Novartis AG Female Infertility Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Female Infertility Drugs Product and Services
2.5.4 Sanofi Female Infertility Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Female Infertility Drugs Sales by Manufacturer
3.1 Global Female Infertility Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Female Infertility Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Female Infertility Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Female Infertility Drugs Manufacturer Market Share
3.4.2 Top 6 Female Infertility Drugs Manufacturer Market Share
3.5 Global Female Infertility Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Female Infertility Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Female Infertility Drugs Market Size by Region
4.1.1 Global Female Infertility Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Female Infertility Drugs Revenue by Region (2016-2026)
4.2 North America Female Infertility Drugs Revenue (2016-2026)
4.3 Europe Female Infertility Drugs Revenue (2016-2026)
4.4 Asia-Pacific Female Infertility Drugs Revenue (2016-2026)
4.5 South America Female Infertility Drugs Revenue (2016-2026)
4.6 Middle East and Africa Female Infertility Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Female Infertility Drugs Sales in Volume by Type (2016-2026)
5.2 Global Female Infertility Drugs Revenue by Type (2016-2026)
5.3 Global Female Infertility Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Female Infertility Drugs Sales in Volume by Application (2016-2026)
6.2 Global Female Infertility Drugs Revenue by Application (2016-2026)
6.3 Global Female Infertility Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Female Infertility Drugs Sales by Type (2016-2026)
7.2 North America Female Infertility Drugs Sales by Application (2016-2026)
7.3 North America Female Infertility Drugs Market Size by Country
7.3.1 North America Female Infertility Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Female Infertility Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Female Infertility Drugs Sales by Type (2016-2026)
8.2 Europe Female Infertility Drugs Sales by Application (2016-2026)
8.3 Europe Female Infertility Drugs Market Size by Country
8.3.1 Europe Female Infertility Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Female Infertility Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Female Infertility Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Female Infertility Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Female Infertility Drugs Market Size by Region
9.3.1 Asia-Pacific Female Infertility Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Female Infertility Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Female Infertility Drugs Sales by Type (2016-2026)
10.2 South America Female Infertility Drugs Sales by Application (2016-2026)
10.3 South America Female Infertility Drugs Market Size by Country
10.3.1 South America Female Infertility Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Female Infertility Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Female Infertility Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Female Infertility Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Female Infertility Drugs Market Size by Country
11.3.1 Middle East & Africa Female Infertility Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Female Infertility Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Female Infertility Drugs Typical Distributors
12.3 Female Infertility Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Female Infertility Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Female Infertility Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Allergan Plc Basic Information, Manufacturing Base and Competitors
Table 4. Allergan Plc Major Business
Table 5. Allergan Plc Female Infertility Drugs Product and Services
Table 6. Allergan Plc Female Infertility Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Ferring BV Basic Information, Manufacturing Base and Competitors
Table 8. Ferring BV Major Business
Table 9. Ferring BV Female Infertility Drugs Product and Services
Table 10. Ferring BV Female Infertility Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 12. Merck KGaA Major Business
Table 13. Merck KGaA Female Infertility Drugs Product and Services
Table 14. Merck KGaA Female Infertility Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 16. Novartis AG Major Business
Table 17. Novartis AG Female Infertility Drugs Product and Services
Table 18. Novartis AG Female Infertility Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Major Business
Table 21. Sanofi Female Infertility Drugs Product and Services
Table 22. Sanofi Female Infertility Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Female Infertility Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 24. Global Female Infertility Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Female Infertility Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Female Infertility Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Female Infertility Drugs Production Site of Key Manufacturer
Table 28. Global Female Infertility Drugs Sales by Region (2016-2021e) & (K Units)
Table 29. Global Female Infertility Drugs Sales by Region (2021-2026) & (K Units)
Table 30. Global Female Infertility Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 31. Global Female Infertility Drugs Revenue by Region (2021-2026) & (USD Million)
Table 32. Global Female Infertility Drugs Sales by Type (2016-2021e) & (K Units)
Table 33. Global Female Infertility Drugs Sales by Type (2021-2026) & (K Units)
Table 34. Global Female Infertility Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 35. Global Female Infertility Drugs Revenue by Type (2021-2026) & (USD Million)
Table 36. Global Female Infertility Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 37. Global Female Infertility Drugs Price by Type (2021-2026) & (USD/Unit)
Table 38. Global Female Infertility Drugs Sales by Application (2016-2021e) & (K Units)
Table 39. Global Female Infertility Drugs Sales by Application (2021-2026) & (K Units)
Table 40. Global Female Infertility Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 41. Global Female Infertility Drugs Revenue by Application (2021-2026) & (USD Million)
Table 42. Global Female Infertility Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 43. Global Female Infertility Drugs Price by Application (2021-2026) & (USD/Unit)
Table 44. North America Female Infertility Drugs Sales by Country (2016-2021e) & (K Units)
Table 45. North America Female Infertility Drugs Sales by Country (2021-2026) & (K Units)
Table 46. North America Female Infertility Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 47. North America Female Infertility Drugs Revenue by Country (2021-2026) & (USD Million)
Table 48. North America Female Infertility Drugs Sales by Type (2016-2021e) & (K Units)
Table 49. North America Female Infertility Drugs Sales by Type (2021-2026) & (K Units)
Table 50. North America Female Infertility Drugs Sales by Application (2016-2021e) & (K Units)
Table 51. North America Female Infertility Drugs Sales by Application (2021-2026) & (K Units)
Table 52. Europe Female Infertility Drugs Sales by Country (2016-2021e) & (K Units)
Table 53. Europe Female Infertility Drugs Sales by Country (2021-2026) & (K Units)
Table 54. Europe Female Infertility Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 55. Europe Female Infertility Drugs Revenue by Country (2021-2026) & (USD Million)
Table 56. Europe Female Infertility Drugs Sales by Type (2016-2021e) & (K Units)
Table 57. Europe Female Infertility Drugs Sales by Type (2021-2026) & (K Units)
Table 58. Europe Female Infertility Drugs Sales by Application (2016-2021e) & (K Units)
Table 59. Europe Female Infertility Drugs Sales by Application (2021-2026) & (K Units)
Table 60. Asia-Pacific Female Infertility Drugs Sales by Region (2016-2021e) & (K Units)
Table 61. Asia-Pacific Female Infertility Drugs Sales by Region (2021-2026) & (K Units)
Table 62. Asia-Pacific Female Infertility Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 63. Asia-Pacific Female Infertility Drugs Revenue by Region (2021-2026) & (USD Million)
Table 64. Asia-Pacific Female Infertility Drugs Sales by Type (2016-2021e) & (K Units)
Table 65. Asia-Pacific Female Infertility Drugs Sales by Type (2021-2026) & (K Units)
Table 66. Asia-Pacific Female Infertility Drugs Sales by Application (2016-2021e) & (K Units)
Table 67. Asia-Pacific Female Infertility Drugs Sales by Application (2021-2026) & (K Units)
Table 68. South America Female Infertility Drugs Sales by Country (2016-2021e) & (K Units)
Table 69. South America Female Infertility Drugs Sales by Country (2021-2026) & (K Units)
Table 70. South America Female Infertility Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 71. South America Female Infertility Drugs Revenue by Country (2021-2026) & (USD Million)
Table 72. South America Female Infertility Drugs Sales by Type (2016-2021e) & (K Units)
Table 73. South America Female Infertility Drugs Sales by Type (2021-2026) & (K Units)
Table 74. South America Female Infertility Drugs Sales by Application (2016-2021e) & (K Units)
Table 75. South America Female Infertility Drugs Sales by Application (2021-2026) & (K Units)
Table 76. Middle East & Africa Female Infertility Drugs Sales by Country (2016-2021e) & (K Units)
Table 77. Middle East & Africa Female Infertility Drugs Sales by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Female Infertility Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 79. Middle East & Africa Female Infertility Drugs Revenue by Country (2021-2026) & (USD Million)
Table 80. Middle East & Africa Female Infertility Drugs Sales by Type (2016-2021e) & (K Units)
Table 81. Middle East & Africa Female Infertility Drugs Sales by Type (2021-2026) & (K Units)
Table 82. Middle East & Africa Female Infertility Drugs Sales by Application (2016-2021e) & (K Units)
Table 83. Middle East & Africa Female Infertility Drugs Sales by Application (2021-2026) & (K Units)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Female Infertility Drugs Typical Distributors
Table 87. Female Infertility Drugs Typical Customers
List of Figures
Figure 1. Female Infertility Drugs Picture
Figure 2. Global Female Infertility Drugs Sales Market Share by Type in 2020
Figure 3. Parenteral
Figure 4. Oral
Figure 5. Others
Figure 6. Global Female Infertility Drugs Sales Market Share by Application in 2020
Figure 7. Fertility Clinics
Figure 8. Hospitals
Figure 9. Cryobanks
Figure 10. Global Female Infertility Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Female Infertility Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Female Infertility Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Female Infertility Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Female Infertility Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Female Infertility Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Female Infertility Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Female Infertility Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Female Infertility Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Female Infertility Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Female Infertility Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Female Infertility Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Female Infertility Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Female Infertility Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Female Infertility Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Female Infertility Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Female Infertility Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Female Infertility Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Female Infertility Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Female Infertility Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Female Infertility Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Female Infertility Drugs Sales (2016-2026) & (K Units)
Figure 32. Global Female Infertility Drugs Production Capacity (2016-2026) & (K Units)
Figure 33. Global Female Infertility Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Female Infertility Drugs Market Drivers
Figure 35. Female Infertility Drugs Market Restraints
Figure 36. Female Infertility Drugs Market Trends
Figure 37. Global Female Infertility Drugs Sales Market Share by Manufacturer in 2020
Figure 38. Global Female Infertility Drugs Revenue Market Share by Manufacturer in 2020
Figure 39. Female Infertility Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Female Infertility Drugs Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Female Infertility Drugs Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Female Infertility Drugs Sales Market Share by Region (2016-2026)
Figure 43. Global Female Infertility Drugs Revenue Market Share by Region (2016-2026)
Figure 44. North America Female Infertility Drugs Revenue (2016-2026) & (USD Million)
Figure 45. Europe Female Infertility Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Female Infertility Drugs Revenue (2016-2026) & (USD Million)
Figure 47. South America Female Infertility Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Female Infertility Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Global Female Infertility Drugs Sales Market Share by Type (2016-2026)
Figure 50. Global Female Infertility Drugs Revenue Market Share by Type (2016-2026)
Figure 51. Global Female Infertility Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global Female Infertility Drugs Sales Market Share by Application (2016-2026)
Figure 53. Global Female Infertility Drugs Revenue Market Share by Application (2016-2026)
Figure 54. Global Female Infertility Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America Female Infertility Drugs Sales Market Share by Country (2016-2026)
Figure 56. North America Female Infertility Drugs Revenue Market Share by Country (2016-2026)
Figure 57. North America Female Infertility Drugs Sales Market Share by Type (2016-2026)
Figure 58. North America Female Infertility Drugs Sales Market Share by Application (2016-2026)
Figure 59. Europe Female Infertility Drugs Sales Market Share by Country (2016-2026)
Figure 60. Europe Female Infertility Drugs Revenue Market Share by Country (2016-2026)
Figure 61. Europe Female Infertility Drugs Sales Market Share by Type (2016-2026)
Figure 62. Europe Female Infertility Drugs Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Female Infertility Drugs Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Female Infertility Drugs Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Female Infertility Drugs Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Female Infertility Drugs Sales Market Share by Application (2016-2026)
Figure 67. South America Female Infertility Drugs Sales Market Share by Country (2016-2026)
Figure 68. South America Female Infertility Drugs Revenue Market Share by Country (2016-2026)
Figure 69. South America Female Infertility Drugs Sales Market Share by Type (2016-2026)
Figure 70. South America Female Infertility Drugs Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Female Infertility Drugs Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Female Infertility Drugs Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Female Infertility Drugs Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Female Infertility Drugs Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
男性不妊症の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Male infertility is defined as the inability of a male to impregnate his female partner after a year of unprotected intercourse. Scope of the Report: This report focuses on the Male Infertility in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Afr…- 女性避妊薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Female contraceptives, also known as female birth control are methods of preventing pregnancy that primarily involve the female physiology. Scope of the Report: This report focuses on the Female Contraceptive in global market, especially in North America, Europe and Asia-Pacific, South America, Midd…
- 女性の妊娠可能性と妊娠迅速検査の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Scope of the Report: This report focuses on the Female Fertility and Pregnancy Rapid Test in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The retai…
- 世界の女性用スキンケア市場 2021：企業別、地域別、種類・用途別 The Female Skincare market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…
- 世界の女性用フレグランス市場 2021：企業別、地域別、種類・用途別 The Female Fragrance market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…